Skip to content
OpenCapital
Get started

CONMED CNMD EBIT

EBIT at other companies

Vericel logo
VericelVCEL
-$8.06M+37.0%
OSI Systems logo
OSI SystemsOSIS
$53.21M-5.3%
Johnson & Johnson logo
Johnson & JohnsonJNJ
——
Stryker logo
StrykerSYK
——
Boston Scientific logo
Boston ScientificBSX
——
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
——

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.07B-35.6%
Enterprise value$1.89B-24.5%
P/E19.4×+5.5×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Calculated from CONMED’s reported figures.

$25.4Moperating income+$18.4Mincome before tax+$7.1Minterest expense=$25.42M

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's EBIT?
CONMED (CNMD) reported EBIT of $25.42M in Q1 2026.
How has CONMED's EBIT changed year-over-year?
CONMED's EBIT increased by 59.3% year-over-year, from $15.96M to $25.42M.
What is the long-term trend for CONMED's EBIT?
Over 4 years (2021 to 2025), CONMED's EBIT has grown at a -1.7% compound annual growth rate (CAGR), from $109.72M to $102.62M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.